Market Closed - Nasdaq 04:00:00 2024-07-05 pm EDT 5-day change 1st Jan Change
118.4 USD +0.31% Intraday chart for ICU Medical, Inc. -0.34% +18.66%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
ICU Medical, Inc.(NasdaqGS:ICUI) added to Russell 2000 Defensive Index CI
ICU Medical, Inc.(NasdaqGS:ICUI) dropped from Russell Midcap Value Index CI
ICU Medical, Inc.(NasdaqGS:ICUI) dropped from Russell 1000 Index CI
ICU Medical, Inc.(NasdaqGS:ICUI) added to Russell 2000 Index CI
ICU Medical, Inc.(NasdaqGS:ICUI) added to Russell 2000 Value Index CI
ICU Medical, Inc.(NasdaqGS:ICUI) added to Russell 2000 Value-Defensive Index CI
ICU Medical, Inc.(NasdaqGS:ICUI) added to Russell 2000 Dynamic Index CI
ICU Medical, Inc.(NasdaqGS:ICUI) dropped from Russell Midcap Index CI
ICU Medical, Inc.(NasdaqGS:ICUI) dropped from Russell 1000 Value Index CI
ICU Medical, Inc.(NasdaqGS:ICUI) dropped from Russell 1000 Dynamic Index CI
Needham Initiates ICU Medical at Hold MT
Raymond James Upgrades ICU Medical to Outperform From Market Perform MT
ICU Medical Insider Sold Shares Worth $1,303,485, According to a Recent SEC Filing MT
ICU Medical's Q1 Adjusted Earnings, Revenue Decline MT
Earnings Flash (ICUI) ICU MEDICAL Reports Q1 Revenue $566.7M, vs. Street Est of $554M MT
Earnings Flash (ICUI) ICU MEDICAL Posts Q1 EPS $0.96, vs. Street Est of $0.82 MT
ICU Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Transcript : ICU Medical, Inc., Q1 2024 Earnings Call, May 07, 2024
ICU Medical, Inc. Provides Updated Unaudited Earnings Guidance for the Year 2024 CI
Transcript : ICU Medical, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-20-2024 02:15 PM
Icu Medical Inc/de Insider Sold Shares Worth $812,741, According to a Recent SEC Filing MT
Icu Medical Insider Sold Shares Worth $4,386,155, According to a Recent SEC Filing MT
ICU Medical, Inc. Announces the Resignation of Bill Seeger as Nominated Director CI
Icu Medical Insider Sold Shares Worth $1,458,090, According to a Recent SEC Filing MT
Transcript : ICU Medical, Inc. Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-04-2024 07:30 AM
Chart ICU Medical, Inc.
More charts
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
118.4 USD
Average target price
140.8 USD
Spread / Average Target
+18.97%
Consensus
  1. Stock Market
  2. Equities
  3. ICUI Stock
  4. News ICU Medical, Inc.
  5. Icu Medical Insider Sold Shares Worth $4,386,155, According to a Recent SEC Filing